
Cilengitide is a cyclic peptide containing RGD sequence.
The peptide alpha v beta 3 integrin ligand based on the body, through the integrated use of cyclization, spatial filtering and methylation scanning and, to the alpha v beta 3 integrin with high affinity and selectivity.
Test shows that the peptides not only can inhibit the growth of melanoma and gliomas, and cooperate with radiotherapy can improve other tumors, such as the cure rate of the head and neck squamous cell cancer, has good market prospects and potential.
In peptide synthesis, Cilengitide by solid phase peptide synthesis technology combined with liquid phase peptide synthesis technology.
Storage: - 20 ℃ under freeze dry, avoid light preservation remark: used only for research, not for human body